Filing Flows › Revolution Medicines (RVMD) › Stock forecast & fair value
Revolution Medicines (RVMD) stock forecast and price target
Revolution Medicines (RVMD) trades at $192.28. 24 analysts' median price target is $262.50 (+37%), from $179.00 to $338.00.
Revolution Medicines' latest quarter
Revolution Medicines, Q3 2026: revenue $198M, operating margin -188.9%, net loss $407M, operating cash flow −$416M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for RVMD stock?
The median of 24 analysts' 12-month targets is $262.50, +37% from $192.28; the range is $179.00 to $338.00. The average rating is strong buy.
Does Revolution Medicines usually beat earnings estimates?
It beat the consensus EPS estimate in 20% of the quarters on record.
Is RVMD stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.